November 4, 2023 Enhancing TCR-T Responses and Overcoming the Tumor Microenvironment in Combination with a TGFβ-specific CAR Read Article
August 31, 2023 Manufacturing of CD19/CD20 Bispecific CAR-T Cell Therapy (IMPT-514) for the Treatment of Systemic Lupus Erythematosus Read Article
November 16, 2022 Next generation CAR-T incorporating an inhibitory CAR (iCAR) for increased safety in solid tumors Read Article
April 12, 2022 Dual CAR T cells selectively target HER2-expressing tumor cells with HLA loss of heterozygosity Read Article
April 12, 2022 Incorporation of inhibitory domains into chimeric antigen receptors designed to reduce on-target-off-tumor toxicity in solid tumor treatment Read Article
